New Drug Increases Oxygen Uptake, Exercise Capacity in Genetic Heart Disease: Clinical Trial

An international clinical trial found that new drug aficamten boosts exercise capacity and quality of life for obstructive hypertrophic cardiomyopathy patients.

lzf/Shutterstock

Imagine struggling to catch your breath and feeling chest pains just from climbing a flight of stairs.

For many living with the genetic heart condition obstructive hypertrophic cardiomyopathy (HCM), this is a harsh reality. But a newly tested drug offers hope to those weighed down by the disease.